Home Home
 
Floaters, FDA:
Floater Types-Success Floater Types-Success
F.D.A. and Floaters F.D.A. and Floaters
 
Cost and Candidate:
Cost and Insurance Cost and Insurance
Candidate? Candidate?
Young Patients Young Patients
 
Laser Treatment:
Our Procedure Our Procedure
Before/After Photos Before/After Photos
Science Background Science Background
Patient Testimonials Patient Testimonials
Our Contributions Our Contributions
Why Few Doctors Why Few Doctors
 
Safety:
Benefits and Risks Benefits and Risks
Our Floater Study Our Floater Study
Protecting the retina Protecting the retina
Operative Permit Operative Permit
 
Our Equipment:
Our Laser Our Laser
Our Contact Lenses Our Contact Lenses
 
Other Treatment:
Vitrectomy Vitrectomy
 
More Information:
Our Book Our Book
Eleven Most Interesting Cases Eleven Most Interesting Cases
World literature listing World literature listing
Links Links
 
Seeing Dr. Karickhoff:
Exam. In Your City Exam. In Your City
You In Our Office You In Our Office
International Patients International Patients
Map, Airports, Airlines, Train, Motels, Subway Map, Airports, Airlines, Train, Motels, Subway
Fun In Falls Church Fun In Falls Church
Seeing Washington Seeing Washington
 
Your Surgeon:
Know Dr. Karickhoff - Beyond Floaters Know Dr. Karickhoff - Beyond Floaters
Audio Greeting from Dr. Karickhoff Audio Greeting from Dr. Karickhoff
Our Goals Our Goals
Our Laser Experience Our Laser Experience
Our Gallery Our Gallery
Our Firsts Our Firsts
 
Ocular Innovation:
Why Innovate? Why Innovate?
Dr. K's Unique Career in Innovation, Photos & his Curriculum Vitae Dr. K's Unique Career in Innovation, Photos & his Curriculum Vitae
Dr. K's Video On Innovation Basics Dr. K's Video On Innovation Basics
Ocular Innovation Awards Ocular Innovation Awards
Dr. K. on Advanced Innovation Tasks (for doctors) Dr. K. on Advanced Innovation Tasks (for doctors)
 
Contact Us Contact Us
 

OUR FORMAL FLOATER STUDY

Image

 

(In experienced hands, laser treatment of eye floaters is perhaps the safest procedure of intraocular eye surgery. The U. S. Food and Drug Administration when approving YAG lasers for this procedure, classified this as a non-significant risk procedure.)

In June 2002 we began our formal research study to determine the effectiveness and safety of laser treatment of eye floaters. The study had been formally reviewed to ensure that the study was well designed, all possible subject safeguards were built in, any complications would be promptly reported, and subjects would be informed about all aspects of the study including the risks and benefits.

The preparation for this study was extensive.  The U. S. Food and Drug Administration had not previously approved the use of a YAG laser to treat vitreous opacities.  Therefore, our seven inch thick application, along with our 61 patient pilot study, was submitted to them to obtain an Investigational Device Exemption for use of a YAG laser in our study.  They ruled that our study was a non-significant risk device study and further ruled that a conventional YAG laser could be used in our study without an Investigational Device Exemption.  The study was then organized under FDA guidelines.  Another extensive document for the study was submitted to the Inova Fairfax Hospital Institutional Review Board of Falls Church, Virginia.  This hospital is consistently ranked in the top 100 hospitals in America.  The Board voted to approve and to monitor our study.  An informed consent document approved by the Institutional Review Board was obtained from each patient.  All data and progress of the study was sent to that Board and also to the FDA.  These important steps make the study eligible for publication in peer review journals.  One year follow up of the last patient in our study was obtained in March 2005.
 
The results of the Study were:

1) the laser procedure was successful (using our five criteria of success) in 92 per cent of patients,

2) when the procedure was not successful, no patient was made worse, there was no harm done, and there was no evidence that  a procedure had been done, and

3) there were no significant complications.